- Home
- EDUC vs IMRN Comparison
EDUC vs IMRN Comparison
Compare EDUC & IMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDUC
- IMRN
- Stock Information
- Founded
- EDUC 1965
- IMRN 1994
- Country
- EDUC United States
- IMRN Australia
- Employees
- EDUC N/A
- IMRN N/A
- Industry
- EDUC Consumer Specialties
- IMRN Biotechnology: Pharmaceutical Preparations
- Sector
- EDUC Consumer Discretionary
- IMRN Health Care
- Exchange
- EDUC Nasdaq
- IMRN Nasdaq
- Market Cap
- EDUC 13.4M
- IMRN 14.4M
- IPO Year
- EDUC N/A
- IMRN N/A
- Fundamental
- Price
- EDUC $1.34
- IMRN $1.60
- Analyst Decision
- EDUC
- IMRN
- Analyst Count
- EDUC 0
- IMRN 0
- Target Price
- EDUC N/A
- IMRN N/A
- AVG Volume (30 Days)
- EDUC 742.1K
- IMRN 392.3K
- Earning Date
- EDUC 10-09-2025
- IMRN 08-29-2025
- Dividend Yield
- EDUC N/A
- IMRN N/A
- EPS Growth
- EDUC N/A
- IMRN N/A
- EPS
- EDUC N/A
- IMRN N/A
- Revenue
- EDUC $29,415,900.00
- IMRN $4,777,422.00
- Revenue This Year
- EDUC N/A
- IMRN N/A
- Revenue Next Year
- EDUC N/A
- IMRN N/A
- P/E Ratio
- EDUC N/A
- IMRN N/A
- Revenue Growth
- EDUC N/A
- IMRN 48.63
- 52 Week Low
- EDUC $0.92
- IMRN $1.42
- 52 Week High
- EDUC $2.11
- IMRN $2.48
- Technical
- Relative Strength Index (RSI)
- EDUC 44.81
- IMRN 32.28
- Support Level
- EDUC $1.29
- IMRN $1.54
- Resistance Level
- EDUC $1.73
- IMRN $1.67
- Average True Range (ATR)
- EDUC 0.12
- IMRN 0.14
- MACD
- EDUC -0.02
- IMRN -0.06
- Stochastic Oscillator
- EDUC 15.91
- IMRN 18.87
About EDUC Educational Development Corporation
Educational Development Corp is the United States trade publisher of the line of educational children's books produced in the United Kingdom. Its business activity functions with two reportable segments: PaperPie and Publishing. The Publishing Division segment markets its products to retail accounts, which include books, school supplies, toy and gift stores and museums, through commissioned sales representatives, trade and specialty wholesalers and an internal telesales group.
About IMRN Immuron Limited
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company with a proprietary technology platform focused on polyclonal antibodies that can address unmet medical needs. The company's commercial products are: Travelan (an orally administered passive product indicated to reduce the risk of travelers' diarrhea and minor gastrointestinal disorders), and Protectyn, which is marketed as an immune supplement. Additionally, it has two clinical products in development, IMM124-E and IMM529, for the treatment of multiple high-value enteric disease indications. The firm has two reportable segments: Hyper-immune products, which derive maximum revenue, and Research and development. Geographically, the company generates maximum revenue from Australia, followed by the USA and Canada.